Key Takeaways
- • The U.S. Department of Justice rescheduled state-licensed medical marijuana products from Schedule I to Schedule III under the Controlled Substances Act, loosening federal restrictions on medical cannabis.
- • Congressman Steve Cohen (TN-9), the leading Congressional advocate for marijuana decriminalization, welcomed the DOJ decision but characterized it as "a small step in the right direction" with limited scope.
- • The rescheduling does not affect recreational marijuana, which remains Schedule I, and does not eliminate federal criminal penalties including disqualification from federal nutrition assistance and restrictions on federal housing.
- • Congressman Cohen held a press conference on April 20 with formerly incarcerated individuals and major advocacy organizations including NORML, ACLU, Drug Policy Alliance, and Law Enforcement Action Partnership, calling for complete descheduling of cannabis at the federal level.
- • The Congressman explicitly called on the Trump administration to expedite descheduling of cannabis, signaling continued legislative pressure to remove marijuana entirely from the Controlled Substances Act rather than merely reclassifying it.
Summary
The Department of Justice announced a decision to reschedule state-licensed medical marijuana products to Schedule III of the Controlled Substances Act, marking a shift in federal cannabis policy that has drawn cautiously optimistic response from leading Congressional advocates. Congressman Steve Cohen, whose Tennessee district he represents as a long-standing proponent of marijuana decriminalization, acknowledged the regulatory change while emphasizing its limited practical scope and calling for more comprehensive reform.
Cohen's statement framed the rescheduling as incremental progress but highlighted a critical distinction between rescheduling and descheduling. While moving medical marijuana to Schedule III reduces restrictions on state-licensed products, the decision leaves recreational marijuana classified under Schedule I and does not alter the federal criminal penalties associated with possession. These penalties include disqualification from federal nutrition assistance programs and restrictions on federal housing eligibility—consequences Cohen characterized as "disproportionately harsh life-altering" outcomes affecting individuals with marijuana-related convictions.
On April 20, Cohen convened a press conference with individuals formerly incarcerated in federal prison for marijuana offenses and a coalition of advocacy organizations, including the National Organization for the Reform of Marijuana Laws (NORML), American Civil Liberties Union (ACLU), Drug Policy Alliance (DPA), Students for Sensible Drug Policy (SSDP), Families Against Mandatory Minimums (FAMM), and Law Enforcement Action Partnership (LEAP). The event underscored the human and policy dimensions of federal cannabis classification, with Cohen subsequently participating in a policy briefing with men whose sentences had been commuted.
Cohen's legislative trajectory positions him to maintain pressure on the administration for complete cannabis descheduling—a step that would remove marijuana entirely from the Controlled Substances Act rather than merely reclassifying it within the regulatory framework. He explicitly called on the Trump administration to expedite this broader descheduling effort, signaling that Congressional advocates view the current rescheduling as a waypoint rather than an endpoint in federal cannabis policy reform.
Cohen's statement framed the rescheduling as incremental progress but highlighted a critical distinction between rescheduling and descheduling. While moving medical marijuana to Schedule III reduces restrictions on state-licensed products, the decision leaves recreational marijuana classified under Schedule I and does not alter the federal criminal penalties associated with possession. These penalties include disqualification from federal nutrition assistance programs and restrictions on federal housing eligibility—consequences Cohen characterized as "disproportionately harsh life-altering" outcomes affecting individuals with marijuana-related convictions.
On April 20, Cohen convened a press conference with individuals formerly incarcerated in federal prison for marijuana offenses and a coalition of advocacy organizations, including the National Organization for the Reform of Marijuana Laws (NORML), American Civil Liberties Union (ACLU), Drug Policy Alliance (DPA), Students for Sensible Drug Policy (SSDP), Families Against Mandatory Minimums (FAMM), and Law Enforcement Action Partnership (LEAP). The event underscored the human and policy dimensions of federal cannabis classification, with Cohen subsequently participating in a policy briefing with men whose sentences had been commuted.
Cohen's legislative trajectory positions him to maintain pressure on the administration for complete cannabis descheduling—a step that would remove marijuana entirely from the Controlled Substances Act rather than merely reclassifying it within the regulatory framework. He explicitly called on the Trump administration to expedite this broader descheduling effort, signaling that Congressional advocates view the current rescheduling as a waypoint rather than an endpoint in federal cannabis policy reform.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.